1,4,7-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecane has been researched along with Disease Models, Animal in 3 studies
*Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bedse, G; Gaulden, AD; Hartley, ND; Kingsley, PJ; Marnett, LJ; Neale, E; Patel, S; Patrick, TA; Plath, N; Uddin, MJ | 1 |
| Liu, T; Lowell, AN; Lund-Katz, S; Nakao, Y; Paulose, B; Qiao, H; Woods, M; Yamakoshi, Y; Zhang, H; Zhou, R | 1 |
| FitzGerald, GA; Ishikawa, T; Liu, T; Lowell, AN; Oriana, S; Qiao, H; Ricciotti, E; Wang, M; Yamakoshi, Y; Zhang, H; Zhou, R | 1 |
3 other study(ies) available for 1,4,7-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecane and Disease Models, Animal
| Article | Year |
|---|---|
Functional Redundancy Between Canonical Endocannabinoid Signaling Systems in the Modulation of Anxiety.
Topics: Adaptation, Ocular; Animals; Anti-Anxiety Agents; Anxiety; Arachidonic Acids; Benzodioxoles; Brain; Cannabinoid Receptor Agonists; Cyclohexanols; Disease Models, Animal; Dronabinol; Endocannabinoids; Excitatory Postsynaptic Potentials; Glycerides; Heterocyclic Compounds, 1-Ring; Locomotion; Male; Mice; Mice, Inbred ICR; Piperidines; Polyunsaturated Alkamides; Pyridines; Signal Transduction | 2017 |
LDL-based nanoparticles for contrast enhanced MRI of atheroplaques in mouse models.
Topics: Animals; Atherosclerosis; Contrast Media; Coordination Complexes; Disease Models, Animal; Gadolinium; Heterocyclic Compounds, 1-Ring; Lipoproteins, LDL; Magnetic Resonance Imaging; Metal Nanoparticles; Mice; Mice, Knockout; Radionuclide Imaging | 2011 |
Functionalized low-density lipoprotein nanoparticles for in vivo enhancement of atherosclerosis on magnetic resonance images.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Disease Models, Animal; Gadolinium; Heterocyclic Compounds, 1-Ring; Humans; Lipoproteins, LDL; Magnetic Resonance Imaging; Mice; Mice, Inbred C57BL; Molecular Structure; Nanoparticles; Organometallic Compounds; Radiopharmaceuticals; Tissue Distribution | 2012 |